Risk monitoring and pharmacovigilance of programmed cell death protein 1 / programmed cell death 1 ligand 1 in cancer patients after solid organ transplantation.

Mei, Long; Li, Sa; Fan, Qianqian; Zhao, Bin; Mei, Dan; Took, Roxane; Zhen, Jiancun

Mei, Long; Li, Sa; Fan, Qianqian; Zhao, Bin; Mei, Dan; Took, Roxane; Zhen, Jiancun.

Afiliação

Mei L; Department of Pharmacy, Beijing Jishuitan Hospital, Xicheng District Xinjiekou No. 31, East Beijing 100035, PR China.
Li S; Department of Pharmacy, Beijing Jishuitan Hospital, Xicheng District Xinjiekou No. 31, East Beijing 100035, PR China.
Fan Q; Department of Pharmacy, Peking Union Medical College Hospital, Beijing 100730, PR China.
Zhao B; Department of Pharmacy, Peking Union Medical College Hospital, Beijing 100730, PR China.
Mei D; Department of Pharmacy, Peking Union Medical College Hospital, Beijing 100730, PR China.
Took R; Pharmacy Practice, St. Louis College of Pharmacy, St. Louis MO 63110-1088, United States.
Zhen J; Department of Pharmacy, Beijing Jishuitan Hospital, Xicheng District Xinjiekou No. 31, East Beijing 100035, PR China. Electronic address: zhenjiancun@163.com.

Therapie ; 78(4): 385-392, 2023.

Article em En | MEDLINE | ID: mdl-36481226

Palavras-chave

FAERS; PD-1/PD-L1 inhibitors; Rejection reaction; Solid organ transplantation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Therapie Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google